Actively Recruiting
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Led by Eastern Virginia Medical School · Updated on 2025-03-10
110
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
CONDITIONS
Official Title
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Singleton gestation
- Known or new diagnosis of gestational diabetes without reason for medication
- Age �318 to �350
You will not qualify if you...
- Non-English as primary language
- Known or suspected fetal anomaly or aneuploidy
- Known lower bowel disorder
- Known phenylketonuria
- Prisoners
- Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Macon & Joan Brock Virginia Health Sciences at ODU
Norfolk, Virginia, United States, 23507
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here